-
Mashup Score: 1
52 likes, 2 comments – osu_gynonc_fellowship on April 22, 2024: “Congratulations to our PGY6 fellows Molly and Polly on a successful thesis defense tonight. Also big thanks to our research mentors for t…”.
Source: www.instagram.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15Pelotonia | Profile - 2 month(s) ago
Pelotonia is a community that is determined to see an end to cancer. Together, we’ve saved countless lives. Help us save more.
Source: www.pelotonia.orgCategories: General Medicine News, Hem/OncsTweet-
So excited to register for @Pelotonia today!!!! So amazing to be part of this incredible community that provides life saving research @OSUCCC_James Please donate if you’d like!!! https://t.co/XY5wnv5XMO Some pics through last 3 years with my #1 supporter 😃 https://t.co/T1Yqlt9SeX
-
-
Mashup Score: 0The GOG Foundation, Inc. Business Dinner Meeting - GOG - 1 year(s) ago
The GOG Foundation, Inc. and GOG Partners welcome representatives from participating sites to attend The GOG Foundation, Inc. Dinner Meeting […]
Source: GOGCategories: Hem/Oncs, Latest HeadlinesTweet-
Join me in attending The GOG Foundation, Inc. Dinner Meeting on Thursday, January 26th from 6:30 pm – 9:30 pm ET. For more information on this event for participating sites, go to https://t.co/PoAeqlFcAh. #clinicaltrials #GynecologicOncology #GOGPartners #GOGF @GOG @NRGonc https://t.co/GJBDZW6MvT
-
-
Mashup Score: 0Less is more: Clinical utility of postoperative labs following minimally invasive hysterectomy for endometrial cancer. - 2 year(s) ago
With the increasing rates of same day discharge following minimally invasive surgery for endometrial cancer, the need for and value of routine postoperative testing is unclear.
Categories: Hem/Oncs, Latest HeadlinesTweet-
Routine labs after minimally invasive surgery for endometrial cancer? Our @OSUCCC_James data suggests no… Congrats @mdslightfoot Less is more: Clinical utility of postoperative labs following minimally invasive hysterectomy for endometrial cancer. https://t.co/h3YTKlQMq1
-
-
Mashup Score: 8Pelotonia | Profile - 2 year(s) ago
Pelotonia is a community that is determined to see an end to cancer. Together, we’ve saved countless lives. Help us save more.
Source: www.pelotonia.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Please consider donating to #cancer research Every dollar counts… every dollar goes to #endcancer @Pelotonia @OSUCCC_James @dougulman @OhioStateGCProg @OhioStateMed @OSUWexMed https://t.co/XY5wnv5XMO https://t.co/n8t9s0Eobj
-
-
Mashup Score: 1
PURPOSE To compare taxane maintenance chemotherapy, paclitaxel (P) and paclitaxel poliglumex (PP), with surveillance (S) in women with ovarian, peritoneal, or fallopian tube (O/PC/FT) cancer who attained clinical complete response after first-line platinum-taxane therapy. METHODS Women diagnosed with O/PC/FT cancer who attained clinical complete response after first-line platinum-taxane–based…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @GOG: For more information on this article, click link in bio or go to https://t.co/Ny0wotjkOF. #clinicaltrials #GynecologicOncology #G…
-
-
Mashup Score: 0Casey Cosgrove, MD | OSUCCC – James - 2 year(s) ago
Casey Cosgrove, MD, a gynecologic oncologist at the OSUCCC – James, admits that past Pelotonia rides have given him goosebumps.
Source: The James - OSUCCCCategories: Hem/Oncs, Latest HeadlinesTweet-
Wow! 👇 @Pelotonia has been transformative both personally and professionally… I love our community and our future of a cancerless future @OSUCCC_James #onegoal #endcancer https://t.co/A9tlibe9hL
-
-
Mashup Score: 0
PURPOSE Balstilimab (antiprogrammed death-1) and zalifrelimab (anticytotoxic T-lymphocyte–associated antigen-4) are two new checkpoint inhibitors emerging as promising investigational agents for the treatment of advanced cervical cancer. This phase II trial (ClinicalTrials.gov identifier: NCT03495882) evaluated the combination of balstilimab plus zalifrelimab in patients with recurrent and/or…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Congrats to @omalleygynonc and team on this recent @JCO_ASCO paper! @OSUCCC_James Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study https://t.co/hbXubpA0m8
-
-
Mashup Score: 5
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Oncs, Latest HeadlinesTweet-
. @David_Cohn_MD and I were listening to too much @HamiltonMusical when we came up with this title Check it @OncJournal 👇 The answer is YES and we are working on it @OSUCCC_James Endometrial Cancer: Who lives, who dies, can we improve their story? https://t.co/O2hg26Q6rp
-
-
Mashup Score: 0Pelotonia | Profile - 3 year(s) ago
Pelotonia is a community that is determined to see an end to cancer. Together, we’ve saved countless lives. Help us save more.
Source: pelotonia.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Need I say more… @Pelotonia @OSUCCC_James @OSUWexMed @osugynonc #onegoal #endcancer Ready for an epic ride this year with this guy getting to experience his first ride weekend!!!! Support cancer research and my 💯 mile ride 👇 https://t.co/GRTgDvY63B https://t.co/FuxavFfYaD
-
🔬 https://t.co/swP2v8PSG1